IHS Chemical Week

Regions :: North America :: U.S.

Evonik invests in US biotech firm Algal Scientific

10:21 AM MDT | April 28, 2014 | Deepti Ramesh

Evonik says it is investing in the technology start-up Algal Scientific (Northville, MI). Evonik is part of an investors’ consortium that is investing more than $3 million in a series-A financing round. Algal, under the trade name Algamune, markets 1,3-β-glucan, a polysaccharide that strengthens immune response. The polysaccharide is used as an additive in animal feeds, as a nutritional supplement, and in pharmaceutical formulations, Evonik says. In addition to Evonik, US venture capital firms Formation 8, Independence Equity, and Envy...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa